NIH-funded research R01 grant

Regulatory network of Lyme disease bacteria

Official title: Regulatory Network of the Lyme Disease Pathogen

Funded at Indiana University Indianapolis · NIH-11345865 · Data updated 2026-11-12

A study to understand how the Lyme disease bacteria controls its genes as it moves between ticks and mammals, which could lead to better prevention and treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startJuly 1, 2009
Project endMay 31, 2028
Funding year2026
Award (this year)$461,972
NIH project number5R01AI083640-14
Project IDNIH-11345865 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Lyme disease or those at risk in areas where Borrelia burgdorferi is common might benefit from advances stemming from this research.

Less likely to help

People not exposed to Lyme disease or those not connected to this pathogen’s research may not directly benefit.

What this research studies

Lyme disease is caused by Borrelia burgdorferi, and this project looks at how the bacterium carefully turns genes on and off during its life cycle in ticks and mammals. The team focuses on a key regulatory pathway called RpoS and how it is controlled, including an investigation into whether BosR helps stabilize rpoS messages rather than acting as a traditional activator. The research combines lab experiments to test the proposed mechanism, aiming to map how these regulatory interactions influence the expression of antigens and virulence factors. Findings could reveal new targets to block infection or improve vaccines and diagnostics for Lyme disease.

Why it matters

Potential benefit: If successful, the work may reveal new targets to prevent infection, improve diagnostics, and guide future therapies for Lyme disease.

How similar studies have gone: Previous research has established components of the RpoS pathway; this project explores a novel RNA-binding role for BosR, which could be a new, unproven mechanism.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Yang, X. Frank — Indiana University Indianapolis
  • Study coordinator: Yang, X. Frank

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.